Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments
An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-termina...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2000-06, Vol.397 (2-3), p.291-296 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 296 |
---|---|
container_issue | 2-3 |
container_start_page | 291 |
container_title | European journal of pharmacology |
container_volume | 397 |
creator | Scarselli, M Armogida, M Chiacchio, S DeMontis, M G Colzi, A Corsini, G U Maggio, R |
description | An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins. |
doi_str_mv | 10.1016/S0014-2999(00)00272-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71173762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71173762</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-970002eafbabc9dd6113eac0368e494e66bf6fd3415ed4b774840075bea714823</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhH0A0VL4CSCfUHswrB3Hbo6It1QJicc5sp0NCkriYDtS--9pRelpVqNvRqMl5ILDNQeubt4BuGSiKIo5wAJAaMH0EZke7Ak5jfEbAPJC5CdkwmEpJRdqStZv6HwfU5PG1Pie-prWY-92t2lp5QfTNT3S-7mICxrQ4ZB8oHZDnWe4HgLGuI_tQM-o6SvqTLB-vWlZwrB1t0WHZB3MV4d9imfkuDZtxPO9zsjn48PH3TNbvT693N2u2MCFSKzQ29UCTW2NdUVVKc4zNA4ytURZSFTK1qquMslzrKTVWi4lgM4tGs3lUmQzcvXXOwT_M2JMZddEh21revRjLDXnOtNqB17uwdF2WJVDaDoTNuX_r7JfeUZseQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71173762</pqid></control><display><type>article</type><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</creator><creatorcontrib>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</creatorcontrib><description>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</description><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/S0014-2999(00)00272-7</identifier><identifier>PMID: 10844126</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Animals ; Apomorphine - pharmacology ; Binding, Competitive - drug effects ; Clozapine - pharmacology ; Colforsin - pharmacology ; COS Cells ; Cyclic AMP - metabolism ; Dopamine - pharmacology ; Dopamine Agonists - metabolism ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - pharmacology ; Dose-Response Relationship, Drug ; Gene Expression ; Haloperidol - pharmacology ; Membranes - metabolism ; Peptide Fragments - drug effects ; Peptide Fragments - genetics ; Peptide Fragments - physiology ; Pergolide - pharmacology ; Quinpirole - pharmacology ; Radioligand Assay ; Rats ; Receptors, Dopamine D2 - drug effects ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D2 - physiology ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - physiology ; Spiperone - analogs & derivatives ; Spiperone - metabolism ; Spiperone - pharmacology ; Transfection ; Tritium</subject><ispartof>European journal of pharmacology, 2000-06, Vol.397 (2-3), p.291-296</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10844126$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scarselli, M</creatorcontrib><creatorcontrib>Armogida, M</creatorcontrib><creatorcontrib>Chiacchio, S</creatorcontrib><creatorcontrib>DeMontis, M G</creatorcontrib><creatorcontrib>Colzi, A</creatorcontrib><creatorcontrib>Corsini, G U</creatorcontrib><creatorcontrib>Maggio, R</creatorcontrib><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</description><subject>Animals</subject><subject>Apomorphine - pharmacology</subject><subject>Binding, Competitive - drug effects</subject><subject>Clozapine - pharmacology</subject><subject>Colforsin - pharmacology</subject><subject>COS Cells</subject><subject>Cyclic AMP - metabolism</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Agonists - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gene Expression</subject><subject>Haloperidol - pharmacology</subject><subject>Membranes - metabolism</subject><subject>Peptide Fragments - drug effects</subject><subject>Peptide Fragments - genetics</subject><subject>Peptide Fragments - physiology</subject><subject>Pergolide - pharmacology</subject><subject>Quinpirole - pharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Receptors, Dopamine D2 - drug effects</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D2 - physiology</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - physiology</subject><subject>Spiperone - analogs & derivatives</subject><subject>Spiperone - metabolism</subject><subject>Spiperone - pharmacology</subject><subject>Transfection</subject><subject>Tritium</subject><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtPwzAQhH0A0VL4CSCfUHswrB3Hbo6It1QJicc5sp0NCkriYDtS--9pRelpVqNvRqMl5ILDNQeubt4BuGSiKIo5wAJAaMH0EZke7Ak5jfEbAPJC5CdkwmEpJRdqStZv6HwfU5PG1Pie-prWY-92t2lp5QfTNT3S-7mICxrQ4ZB8oHZDnWe4HgLGuI_tQM-o6SvqTLB-vWlZwrB1t0WHZB3MV4d9imfkuDZtxPO9zsjn48PH3TNbvT693N2u2MCFSKzQ29UCTW2NdUVVKc4zNA4ytURZSFTK1qquMslzrKTVWi4lgM4tGs3lUmQzcvXXOwT_M2JMZddEh21revRjLDXnOtNqB17uwdF2WJVDaDoTNuX_r7JfeUZseQ</recordid><startdate>20000602</startdate><enddate>20000602</enddate><creator>Scarselli, M</creator><creator>Armogida, M</creator><creator>Chiacchio, S</creator><creator>DeMontis, M G</creator><creator>Colzi, A</creator><creator>Corsini, G U</creator><creator>Maggio, R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20000602</creationdate><title>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</title><author>Scarselli, M ; Armogida, M ; Chiacchio, S ; DeMontis, M G ; Colzi, A ; Corsini, G U ; Maggio, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-970002eafbabc9dd6113eac0368e494e66bf6fd3415ed4b774840075bea714823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Apomorphine - pharmacology</topic><topic>Binding, Competitive - drug effects</topic><topic>Clozapine - pharmacology</topic><topic>Colforsin - pharmacology</topic><topic>COS Cells</topic><topic>Cyclic AMP - metabolism</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Agonists - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gene Expression</topic><topic>Haloperidol - pharmacology</topic><topic>Membranes - metabolism</topic><topic>Peptide Fragments - drug effects</topic><topic>Peptide Fragments - genetics</topic><topic>Peptide Fragments - physiology</topic><topic>Pergolide - pharmacology</topic><topic>Quinpirole - pharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Receptors, Dopamine D2 - drug effects</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D2 - physiology</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - physiology</topic><topic>Spiperone - analogs & derivatives</topic><topic>Spiperone - metabolism</topic><topic>Spiperone - pharmacology</topic><topic>Transfection</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scarselli, M</creatorcontrib><creatorcontrib>Armogida, M</creatorcontrib><creatorcontrib>Chiacchio, S</creatorcontrib><creatorcontrib>DeMontis, M G</creatorcontrib><creatorcontrib>Colzi, A</creatorcontrib><creatorcontrib>Corsini, G U</creatorcontrib><creatorcontrib>Maggio, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scarselli, M</au><au>Armogida, M</au><au>Chiacchio, S</au><au>DeMontis, M G</au><au>Colzi, A</au><au>Corsini, G U</au><au>Maggio, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2000-06-02</date><risdate>2000</risdate><volume>397</volume><issue>2-3</issue><spage>291</spage><epage>296</epage><pages>291-296</pages><issn>0014-2999</issn><abstract>An N-terminal dopamine D(2s) receptor clone was constructed and coexpressed in COS-7 cells together with a separate gene fragment coding for the C-terminal sequence of the dopamine D(2s) receptor. The truncated receptor (referred to as D(2trunc)) contained transmembrane domains I-V and the N-terminal portion of the third cytoplasmic loop, whereas the C-terminal receptor fragment (referred to as D(2tail)) contained transmembrane domains VI and VII and the adjacent intra- and extracellular sequences of the dopamine D(2s) receptor. Expression in COS-7 cells of either of these two polypeptides alone did not result in any detectable [3H]methylspiperone binding activity. However, specific [3H]methylspiperone binding could be observed after coexpression of the D(2trunc) and D(2tail) gene constructs; the number of receptors present on the plasma membrane was about 10% with respect to that of the wild type. The binding properties of the coexpressed fragments were similar to those of the wild-type dopamine D(2s) receptor for agonists and antagonists. Functional stimulation of the cotransfected D(2trunc) and D(2tail) fragments with quinpirole resulted in the inhibition of adenylate cyclase activity. Maximal inhibition corresponds to a 28% decrease in forskolin-stimulated adenylate cyclase. The apparent IC(50) of quinpirole was 5.1+/-0.3 mcM. These findings confirm and extend analogous data for other G protein-coupled receptors and indicate that this phenomenon is of general importance for the entire family of these proteins.</abstract><cop>Netherlands</cop><pmid>10844126</pmid><doi>10.1016/S0014-2999(00)00272-7</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2000-06, Vol.397 (2-3), p.291-296 |
issn | 0014-2999 |
language | eng |
recordid | cdi_proquest_miscellaneous_71173762 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Apomorphine - pharmacology Binding, Competitive - drug effects Clozapine - pharmacology Colforsin - pharmacology COS Cells Cyclic AMP - metabolism Dopamine - pharmacology Dopamine Agonists - metabolism Dopamine Agonists - pharmacology Dopamine Antagonists - pharmacology Dose-Response Relationship, Drug Gene Expression Haloperidol - pharmacology Membranes - metabolism Peptide Fragments - drug effects Peptide Fragments - genetics Peptide Fragments - physiology Pergolide - pharmacology Quinpirole - pharmacology Radioligand Assay Rats Receptors, Dopamine D2 - drug effects Receptors, Dopamine D2 - genetics Receptors, Dopamine D2 - physiology Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - physiology Spiperone - analogs & derivatives Spiperone - metabolism Spiperone - pharmacology Transfection Tritium |
title | Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T13%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reconstitution%20of%20functional%20dopamine%20D(2s)%20receptor%20by%20co-expression%20of%20amino-%20and%20carboxyl-terminal%20receptor%20fragments&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Scarselli,%20M&rft.date=2000-06-02&rft.volume=397&rft.issue=2-3&rft.spage=291&rft.epage=296&rft.pages=291-296&rft.issn=0014-2999&rft_id=info:doi/10.1016/S0014-2999(00)00272-7&rft_dat=%3Cproquest_pubme%3E71173762%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71173762&rft_id=info:pmid/10844126&rfr_iscdi=true |